Genetic screening before prescribing could benefit millions

Peer reviewed - Simulation/modelling

2021-01-29

(Press-News.org) Four million UK patients could benefit annually from genetic testing before being prescribed common medicines, according to new research from the University of East Anglia (UEA) in collaboration with Boots UK and Leiden University (Netherlands). Researchers looked through 2019 NHS dispensing data across the UK to see how many patients are started on new prescriptions each year that could be potentially optimised by genetic testing. They studied 56 medicines, including antidepressants, antibiotics, stomach ulcer treatments and painkillers where there are known drug-gene interactions. And they found that in more than one in five occasions (21.1 per cent) there was the potential for a doctor or pharmacist to take action under international pharmacogenetic guidelines. If this screening was applied to all new prescriptions, an estimated one in 11 (9.1 per cent) would lead to a change of drug or dose, affecting over five million dispensed items. Depending on the results of individual pharmacogenetic tests, they might either get a higher or lower starting dose than normal or be more closely monitored during the early stages of treatment. Pharmacogenomic testing services already working in the Netherlands show that specially-trained GPs and pharmacists can carry out pre-prescribing tests and use the results to give advice on safer and more effective prescribing, delivering better patient outcomes. Essra Youssef, a research pharmacist at UEA's School of Pharmacy, said: "We know over 95 per cent of the population carry a genetic marker that predicts an atypical response to at least one medicine. "Our study looked at nine of these genetic markers, affecting 56 medicines that are commonly dispensed by community pharmacies in the UK. The most common of these are weak opioids, antidepressants and proton-pump inhibitors, which are prescribed to reduce stomach acid. "We wanted to see how pharmacogenetic testing, before being prescribed common medicines, could benefit patients. "We found that around four million patients annually in the UK could benefit from having this new technology. "Better selection of medicines based on a patient's genetic information could mean less side-effects and better treatment outcomes. This not only benefits the patient but also the NHS, as patients may not need to return to their GP so often to change their medication. "It could also reduce hospital visits related to side effects of medicines. The testing process is quite simple in most cases, with a cheek swab sample collected and DNA analysed for genes related to medicines. As the cost of this testing continues to drop, the technology is more likely to represent good value for the NHS." Marc Donovan, Chief Pharmacist at Boots UK, said: "We strongly believe that pharmacy has a key role to play supporting the wider accessibility and use of pharmacogenomics. "Our work shows the benefits that patients and the NHS could get from rolling out a national screening programme as part of their plans to embed pharmacogenomics in clinical practice by 2025, and that this testing could be effectively delivered by community pharmacists. "Last year, around four million people could have had a change in their prescribing, according to our figures. This would have reduced their risk of side effects and could have led to better clinical outcomes."

INFORMATION:

'Estimating the potential impact of implementing pre-emptive pharmacogenetic testing in primary care across the UK' is published in the British Journal of Clinical Pharmacology.

ELSE PRESS RELEASES FROM THIS DATE:

Imaging zebrafish movements in 3D to better understand ALS disease

2021-01-29

An interdisciplinary team of the Institut national de la recherche scientifique (INRS) used an innovative imaging technique for a better understanding of motor deficits in Amyotrophic Lateral Sclerosis (ALS). The researchers were able to follow the escape behaviour of normal and disease zebrafish models, in 3D. Their results have recently been published in Optica, the flagship journal of the Optical Society (OSA). Professor Jinyang Liang, expert in ultra-fast imaging and biophotonics, joined an effort with Professor Kessen Patten, specialist in genetics and neurodegenerative diseases. The two groups were able to track the position of ...

Iowa and Ohio team finds strategy to protect developing brain from prenatal stress in mice

2021-01-29

New research from the University of Iowa and University Hospitals Cleveland Medical Center demonstrates that offspring can be protected from the effects of prenatal stress by administering a neuroprotective compound during pregnancy. Working in a mouse model, Rachel Schroeder, a student in the UI Interdisciplinary Graduate Program in Neuroscience, drew a connection between the work of her two mentors, Hanna Stevens, MD, PhD, UI associate professor of psychiatry and Ida P. Haller Chair of Child and Adolescent Psychiatry, and Andrew A. Pieper, MD, PhD, a former UI faculty member, now Morley-Mather Chair of Neuropsychiatry at Case Western Reserve ...

The Lancet Public Health: Ethnic health disparities among older adults in England equivalent to 20-year age difference, even before COVID-19

2021-01-29

-- Experts call for policy reform to improve ethnic equity of socioeconomic opportunity, service provision, and health outcomes. They also call for long-term studies to investigate how structural and institutional racism generate these ethnic inequalities in health. In 15 out of 17 minority ethnic groups, health-related quality of life in older age (over 55 year-olds) was worse on average for either men, women, or both, than for White British people according to an observational study published in The Lancet Public Health journal. In five of those groups - Bangladeshi, Pakistani, ...

The Lancet: Study estimates that, without vaccination against 10 diseases, mortality in children under five would be 45% higher in low-income and middle-income countries

2021-01-29

Peer-reviewed / Simulation or Modelling / People A new modelling study has estimated that from 2000 to 2030 vaccination against 10 major pathogens - including measles, rotavirus, HPV and hepatitis B - will have prevented 69 million deaths in low-income and middle-income countries (LMICs). The study estimated that, as a result of vaccination programmes, those born in 2019 will experience 72% lower mortality from the 10 diseases over their lifetime than if there was no immunisation. The greatest impact of vaccination was estimated to occur in children under five - mortality from the 10 diseases in ...

Scholars reveal the changing nature of U.S. cities

2021-01-28

Cities are not all the same, or at least their evolution isn't, according to new research from the University of Colorado Boulder. These findings, out this week in Nature Communications Earth and Environment and Earth System Science Data, buck the historical view that most cities in the United States developed in similar ways. Using a century's worth of urban spatial data, the researchers found a long history of urban size (how big a place is) "decoupling" from urban form (the shape and structure of a city), leading to cities not all evolving the same--or even close. The researchers hope that by providing this look at the past with this unique data set, they'll be able to glimpse the future, including the impact of population growth on cities or ...

Experiments show the record of early life could be full of "false positives"

2021-01-28

Boulder, Colo., USA: For most of Earth's history, life was limited to the microscopic realm, with bacteria occupying nearly every possible niche. Life is generally thought to have evolved in some of the most extreme environments, like hydrothermal vents deep in the ocean or hot springs that still simmer in Yellowstone. Much of what we know about the evolution of life comes from the rock record, which preserves rare fossils of bacteria from billions of years ago. But that record is steeped in controversy, with each new discovery (rightfully) critiqued, questioned, and analyzed from every angle. Even then, uncertainty ...

Immune system sets 'tripwire' to protect against viruses

2021-01-28

Scientists are opening new windows into understanding more about the constantly shifting evolutionary arms race between viruses and the hosts they seek to infect. Host organisms and pathogens are in a perennial chess match to exploit each other's weaknesses. Such research holds tantalizing clues for human health since the immune system is on constant alert to deploy counter measures against new viral attacks. But unleashing too much of a defensive response can lead to self-inflicted tissue damage and disease. A new study published in the journal eLife by biologists at the University ...

New biosensors quickly detect coronavirus proteins and antibodies

2021-01-28

Scientists have created a new way to detect the proteins that make up the pandemic coronavirus, as well as antibodies against it. They designed protein-based biosensors that glow when mixed with components of the virus or specific COVID-19 antibodies. This breakthrough could enable faster and more widespread testing in the near future. The research appears in Nature. To diagnose coronavirus infection today, most medical laboratories rely on a technique called RT-PCR, which amplifies genetic material from the virus so that it can be seen. This technique requires specialized staff and equipment. It also consumes lab supplies ...

Study shows when housing quality is poor, children suffer

2021-01-28

Housing instability and homelessness are widely understood to have an impact on health, and certain housing problems have been linked to specific childhood health conditions, such as mold with asthma. But it has not been clear how overall housing quality may affect children--especially those who are at risk from other social determinants of health such as food insecurity or poverty. A new nationally representative study in the Journal of Child Health Care, led by researchers at Nationwide Children's Hospital, has found poor-quality housing is independently associated with poorer pediatric health, ...

Risk analysis helps contend with uncertainty of in-person activities

2021-01-28

As states and municipalities begin to roll out mass vaccination campaigns, some people have dared to ask: When will it be safe to resume "normal" activities again? For those in most parts of the United States, the risk of COVID-19 infection remains extremely high. People now have access to better real-time information about infection rates and transmission at the county or city level, but they still need a framework to help them decide what is safe to do. Social distancing and shutting businesses have reduced the number of cases, but there is mounting pressure to reopen businesses and classrooms. Life is likely to continue in this limbo for some time. A new model co-authored by ...

Genetic screening before prescribing could benefit millions

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: